Bristol-Myers Squibb

	Bristol-Myers Squibb Home
	About Us
	Welcome Message Our Company Overview Diversity Pledge History Awards & Recognition Corporate Governance Executive Committee Board of Directors Reports of Insider Transactions Committee Charters Corporate Governance Guidelines Additional Policies and Guildelines Codes of Conduct Corporate Compliance Description of Comprehensive Compliance Program (PDF) Annual Declaration of Compliance (PDF) Our Websites U.S. International Business Links Insurance Verification Supplier Information Supplier Diversity
	Newsroom
	News Releases Other News Media Kit Company Facts Direct-to-Consumer Communications Code Clinical Trials Disclosure Company History Products R&D Pipeline Company Leadership Executive Speeches & Presentations Publications Awards & Recognition Images & Logos Key Products Research & Development Logos Facilities Media Contacts News Subscription Service RSS Feeds
	Products
	Mead Johnson Together Rx Program
	R&D
	Message From CSO & R&D President Disease Areas of Focus Recent Accomplishments Pipeline Biologics R&D; Facts Clinical Trials Disclosure
	Investors
	Stock Information Historical Price Lookup Tool Stock Calculator SEC Filings Financial Information Earnings Releases Annual Reports Fact Sheet Product Sales Summary Earnings Estimates Analysts News Releases Presentations & Events Shareholder Services Shareholder FAQ Transfer Agent Dividend Reinvestment Plan Dividend Payout History Direct Deposit of Dividends Zimmer Spin-off Info Annual Report by Mail Request Form Annual Stockholder Meeting Corporate Governance E-mail Alerts

Alliances

Alliance News
News Updates
Presentations

Working Together
  Welcome
  A Fast, Focused Approach
  Alliance Management
  What We Are Looking For

Doing Our Part
  Deep Resources
  Our Pipeline of
    Developed Compounds
  Successful Experience
  Case Histories

Getting Started
What We Are Looking For

Corporate Responsibility

Bristol-Myers Squibb Patient
Assistance Foundation, Inc.

Fighting AIDS in Africa

Bristol-Myers Squibb
  Foundation &
  Corporate Philanthropy

Product Integrity

Sustainability: Our Plan for
  Responsible Growth

Environment, Health &
  Safety Policy

Medical Grants And
  Charitable Contributions
  Grants Submission Process
  Medical Grants and Charitable
    Contributions FAQs
  Forms
  Requests For Proposals
Contact Us

Clinical Outcomes And
Research Grants
Virology Fellows Research Program

Position On Key Issues
  Clinical Trial Communication
    Commitment
  Direct-To-Consumer
    Communications Code (PDF)
Policy On Stockholder Rights Plan
Political Contributions
Sustaining Our Intellectual Property

Careers

Search Career Opportunities

Live the Mission

Work With Talented and Diverse People

Drive Our Culture

Reasons To Join
  Benefits (PDF)
  Corporate Responsibility
  Global Diversity

[Top Page] [Search] [Index] [Contact] [Home]

Italicized product names are trademarks of Bristol-Myers Squibb Company or one of its divisions or subsidiaries. Abilify is a trademark of Otsuka Pharmaceutical Co., Ltd. Atripla is a trademark of Bristol-Myers Squibb & Gilead Sciences, LLC. Erbitux is a trademark of ImClone Systems Incorporated. EMSAM is a trademark of Somerset Pharmaceuticals, Inc. Glucophage, Glucovance and Metaglip are trademarks of Merck Santé S.A.S., an associate of Merck KGaA of Darmstadt, Germany. Avapro, Avalide and Plavix are trademarks of sanofi-aventis. Sinemet CR is a trademark of Merck & Co., Inc.